Shaily Engineering Plastics Limited: history, ownership, mission, how it works & makes money

IN | Healthcare | Medical - Instruments & Supplies | NSE

Shaily Engineering Plastics Limited (SHAILY.NS) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

From a modest beginning in 1987 with two injection-molding machines in Halol, Gujarat, Shaily Engineering Plastics has scaled into a global precision plastics powerhouse-expanding to a second plant in Rania in 1994, operating over 200 molding machines across seven facilities (with over 190 machines reported in FY2022-23), launching a UK research hub for medical-device design in FY2023, and completing a pharmaceutical facility expansion in 2024 to serve fast-growing packaging and drug-delivery markets; led by Executive Chairman Mahendra Sanghvi and MD Amit Sanghvi, the publicly listed company (BSE: 501423, NSE: SHAILY) is the only licensed processor of Torlon in India, holds ISO 9001:2015, IATF 16949:2016, ISO 13485:2016, ISO 15378:2015 and MDSAP certifications, exports to over 40 countries, and generates revenue from contract manufacturing, injection-molded components and assemblies across automotive, healthcare, consumer and electronics verticals-reflected in a market capitalization of about ₹10,878 crore and a share price of ₹2,367.40 (52‑week high of ₹2,799.20 on 17 Nov 2025), while planning capital expenditures of approximately ₹300-400 crores over the next 3-4 years to convert one-off orders into multi-year engagements and expand capacity and capabilities.

Shaily Engineering Plastics Limited (SHAILY.NS): Intro

Shaily Engineering Plastics Limited (SHAILY.NS) is an Indian precision plastics and contract manufacturing company focused on consumer durables, furniture, home-care, FMCG/pharma packaging and medical device components. Founded to address a gap in high-precision injection-molded parts, the company has scaled from a small local molder to a multi-facility, automation-led manufacturer with international R&D and pharma capabilities. Shaily Engineering Plastics Limited: History, Ownership, Mission, How It Works & Makes Money History and milestones
  • 1987 - Founded by Mike Sanghvi with two injection molding machines in Halol, Gujarat to serve precision-engineered plastic components need.
  • 1994 - Second facility started at Rania, Gujarat; Rania later became company headquarters to handle growing production.
  • 2007 - Major capacity expansion to support large OEMs and international clients including Ikea, MWV and Electrolux.
  • 2022-23 - Operated over 190 molding machines across seven manufacturing facilities in Halol and Rania, Gujarat, integrating high-speed automation and robotics.
  • FY2023 - Launched a UK-based research facility focused on medical device design to tap a global engineering pool.
  • 2024 - Completed expansion of its pharmaceutical packaging facility to increase capacity for pharma customers.
Ownership and corporate structure
  • Promoter-led ownership with founding family participation (founder: Mike Sanghvi) and public shareholders on NSE (ticker: SHAILY.NS).
  • Structured as a contract manufacturer with verticals across consumer durables, home and furniture, FMCG/pharma packaging, and medical device components.
How Shaily works - capabilities and operations
  • Injection molding fleet: Over 190 molding machines (FY 2022-23) spanning commodity to precision high-tolerance presses.
  • Automation and robotics: High-speed automation for cycle-time reduction, consistent quality and high-volume throughput.
  • Tooling and engineering: In-house toolrooms and design teams supporting rapid prototyping, DFx for manufacturability and global customer requirements.
  • Quality and compliance: Systems to meet international OEM specifications and pharma/medical regulatory standards for packaging and device components.
  • Global engineering access: UK R&D facility (launched FY2023) to augment design capabilities for medical devices and regulated markets.
Business model and revenue drivers
  • Contract manufacturing: Production on long-term OEM contracts and repeat business from large global customers (furniture, appliances, FMCG brands).
  • Value-added services: Tooling, product development, assembly, secondary operations and packaging solutions which command higher margins than pure molding.
  • Sector diversification: Revenue mix across consumer durables, furniture (Ikea-level programs), home-care, FMCG/pharma packaging and medical devices reduces single-sector risk.
  • Capacity scaling: Facility expansions (2007, 2024 pharma expansion) and automation investments improve fixed-cost absorption and gross margin potential.
Selected operational and timeline table
Year Event Operational impact / metric
1987 Company founded in Halol, Gujarat Started with 2 injection molding machines
1994 Second facility at Rania, Gujarat Rania becomes headquarters; expanded production footprint
2007 Major capacity expansion Scaled to serve Ikea, MWV, Electrolux and other global clients
2022-23 Fleet and automation Operated 190+ molding machines across 7 facilities with robotics
FY2023 UK research facility launched Enhanced medical device design capability and global engineer access
2024 Pharma facility expansion completed Increased pharmaceutical packaging capacity
Key competitive advantages
  • Scale of localized manufacturing in Gujarat combined with automation and robotics for cost and quality control.
  • End-to-end capabilities from design and tooling to assembly and regulated packaging for pharma/medical.
  • Long-standing relationships with global OEMs and retailers enabling predictable order books and program continuity.

Shaily Engineering Plastics Limited (SHAILY.NS): History

Shaily Engineering Plastics Limited began as a family-promoted engineering plastics manufacturer and has evolved into a diversified polymer-products group supplying automotive, consumer and industrial customers across India and export markets. Over decades the company expanded from injection-moulded components to finished products and contract manufacturing, backed by process engineering and in-house tooling capabilities.
  • Founded and expanded under the Sanghvi family with a focus on polymer engineering and scale-up of manufacturing facilities.
  • Listed on the Bombay Stock Exchange (BSE) - code 501423 - and the National Stock Exchange (NSE) - ticker SHAILY - enabling access to public capital for growth.
  • Strategic moves into new product lines and export channels have driven industrial diversification and higher-value assemblies.
  • Leadership: Executive Chairman Mahendra Sanghvi (Chemical Engineer, Wayne State University, USA) and Managing Director Amit Sanghvi guide strategy and operations.
  • Board and governance: A professional Board of Directors provides domain and corporate expertise across engineering, finance and compliance.
Item Detail
Market capitalization (as of 15-Dec-2025) ₹10,878 crore
Stock exchanges / Codes BSE: 501423 | NSE: SHAILY
Promoter / Family control Sanghvi family - substantial promoter stake and strategic control
Investor mix Promoters, institutional investors (mutual funds, FIs), retail shareholders
  • Ownership structure is dominated by the Sanghvi family, providing stable promoter control and long-term strategic continuity.
  • Institutional investors hold a material portion of free float, reflecting confidence from asset managers and lending institutions in the company's financial profile and growth prospects.
Mission
  • Deliver engineered plastic solutions with emphasis on product quality, process innovation and customer partnerships across automotive, consumer and industrial verticals.
How It Works & Makes Money
  • Core operations: precision injection moulding, tool and die design, assembly and contract manufacturing for OEMs and branded customers.
  • Revenue drivers: volumes from long-term customer contracts, value-added assemblies, new product introductions and export sales.
  • Margins: product engineering, in-house tooling and scale allow improved gross margins versus commodity polymer players; additional margin uplift comes from higher-value assemblies and integrated services.
  • Capital allocation: reinvestment in capacity, technology and export capabilities financed via retained earnings, promoter support and public market access.
Exploring Shaily Engineering Plastics Limited Investor Profile: Who's Buying and Why?

Shaily Engineering Plastics Limited (SHAILY.NS): Ownership Structure

Shaily Engineering Plastics Limited (SHAILY.NS) is a vertically integrated manufacturer of engineered plastic components, primarily serving the personal-care, FMCG, healthcare and industrial packaging segments. The company emphasizes end-to-end solutions - from polymer compounding and injection molding to value-added assembly - and positions sustainability, quality and shareholder value at the core of its strategy.
  • Mission and Values: Provide end-to-end solutions in plastics, delivering superior quality to customers, higher profitability and value to shareholders, and sustainability for future generations.
  • Customer Delight: Commitment to excellence in performance and products that meet the highest standards of quality and reliability.
  • Systems & Processes: Strong focus on documented systems to ensure consistency, efficiency and predictable delivery.
  • Culture: Encourages passion, determination and proactivity; employees are empowered to take on challenges and innovate.
  • One Shaily: Promotes a family-like team spirit to foster collaboration and unity across operations.
  • Respect & Courtesy: Values interpersonal respect to maintain a harmonious and productive workplace.
How Shaily Works - Core Operations
  • Raw-material sourcing: procurement of polymers, additives and colorants, with in-house compounding to control quality and cost.
  • Manufacturing: injection molding, blow molding, assembly, testing and secondary operations across multiple plants.
  • Product segments: Personal care dispensers and closures, rigid packaging, healthcare components, and engineered assemblies.
  • Quality & R&D: continuous process improvement, product development collaborations and customer-specific tooling solutions.
How Shaily Makes Money
  • Sale of finished components and assemblies to global and domestic FMCG, personal care and healthcare customers (B2B contracts and long-term supply agreements).
  • Value-added services: design, tooling and assembly services that command higher margins than commodity components.
  • In-house compounding reduces input costs and enables margin improvement through backward integration.
  • Scale and export: incremental revenue from export orders and newer geographies, improving utilization of fixed assets.
Ownership and Key Financial Indicators (selected figures)
Item Data / Period
Promoter & Promoter Group holding ~65% (majority stake)
Public & Others ~35%
Revenue (Trailing 12 months / latest reporting) Reported in company filings as a mid-to-high hundreds of crores INR (company reports show steady growth driven by exports and value-added products)
EBITDA / Margin Margins typically reflect benefits from backward integration and product mix; company targets margin improvement via operational efficiency
Capex & Expansion Periodic capital expenditure to expand molding capacity, add assembly lines and enhance compounding capability
Key drivers investors watch
  • Volume growth in personal-care and FMCG segments and share gains in export markets.
  • Realization improvements from high-margin value-added components and assemblies.
  • Raw-material cost management through compounding and procurement efficiencies.
  • Utilization of new capacity and payback on recent capex investments.
Mission Statement, Vision, & Core Values (2026) of Shaily Engineering Plastics Limited.

Shaily Engineering Plastics Limited (SHAILY.NS): Mission and Values

Shaily Engineering Plastics Limited (SHAILY.NS) is an Indian specialty polymers and precision injection-molding company focused on high-performance engineered plastic components for medical devices, automotive, consumer appliances, and industrial applications. The company's mission centers on engineering-driven manufacturing, quality & regulatory compliance, and delivering end-to-end product solutions that combine polymer expertise with automated assembly capabilities. See also: Mission Statement, Vision, & Core Values (2026) of Shaily Engineering Plastics Limited. How It Works Shaily's operational model integrates polymer sourcing, design, molding, secondary processing, assembly and testing to provide turnkey solutions for customers requiring precision and regulatory compliance.
  • Manufacturing footprint: seven facilities located in Halol and Rania, Gujarat, with a combined installed base of over 200 injection molding machines, including high-speed automated presses and robotic handling systems.
  • Polymer specialization: focus on high and ultra-high-performance polymers; Shaily is the only licensed processor of Torlon (polyamide-imide) in India, enabling applications requiring extreme mechanical strength, thermal stability and chemical resistance.
  • End-to-end services: design for manufacturability (DFM), tool design and tooling management, precision injection molding, post-mold secondary operations, automated/semi-automated assembly, testing and final packaging for both regulated (medical) and non-regulated sectors.
Manufacturing and Process Capabilities
  • Injection molding: over 200 machines covering micro to large-tonnage presses with process controls for tight tolerances and high repeatability.
  • Automation & robotics: high-speed automation cells for molding, pick-and-place, inspection and assembly to increase throughput and reduce cycle time variability.
  • Secondary operations integrated on-site:
    • Pad printing and hot stamping for permanent marking and branding.
    • Painting and surface finishes for aesthetic requirements.
    • Ultrasonic welding, thermal staking and laser welding for hermetic assembly.
    • Vacuum metalizing for decorative and reflective surfaces.
  • Assembly platforms: manual, semi-automated and fully automated lines developed in-house to optimize cost vs. volume trade-offs while maintaining quality controls.
Quality, Compliance and Certifications Shaily maintains a rigorous quality management and regulatory framework that supports global customers, especially in medical and automotive sectors.
Certification / Standard Relevance
ISO 9001:2015 Quality management system across operations
IATF 16949:2016 Automotive quality requirements and supplier systems
ISO 13485:2016 Medical device quality management and regulatory compliance
ISO 15378:2015 Primary packaging materials for medicinal products - GMP aligned
MDSAP (Medical Device Single Audit Program) Harmonized medical device regulatory audit acceptance across multiple markets
Revenue Model - How Shaily Makes Money Shaily's income streams derive from a mix of contract manufacturing, value-added assembly services, proprietary processing rights and aftermarket/recurring supplies.
  • Contract manufacturing: tooling, molding and assembly contracts priced on a combination of fixed tooling fees, per-part molding rates and assembly rates; large programs often include multi-year supply agreements with price and volume ramps.
  • Value-added services: revenue from secondary processes (printing, painting, metalizing) and integrated assembly, which command premium margins versus pure molding.
  • Specialty polymers: premium pricing for high-performance materials processing (e.g., Torlon), low-volume/high-complexity parts and regulated medical components.
  • Aftermarket and consumables: supply of spare parts, inserts and periodic repeat orders from medical and industrial customers offering recurring revenue.
  • Export and global OEM supply: direct supply and Tier-1 OEM contracts for automotive and medical markets, often denominated in foreign currencies, reducing concentration risk.
Operational and Financial Drivers (operational metrics and business levers)
Driver Metric / Description
Installed molding capacity 7 plants; >200 injection molding machines with high-speed and large-tonnage capabilities
Automation level Robotic cells and automated assembly lines for high-volume programs to reduce labor intensity and improve OEE
Product mix High-performance polymers (Torlon licensed), medical consumables, automotive components, consumer/industrial parts
Quality certifications ISO 9001, IATF 16949, ISO 13485, ISO 15378, MDSAP - enables premium contracts in regulated segments
Margin levers Higher-margin specialty polymers and value-added services; lower-margin commodity molding offset by volume and automation
Working capital profile Tooling capex up-front; receivable and inventory cycles depend on program stage and customer payment terms
Strategic Advantages
  • Technical depth in engineered polymers and tooling, enabling complex parts with tight tolerances and regulatory traceability.
  • Integrated value chain from DFM and tooling to secondary finishes and automated assembly reduces vendor handoffs and improves gross margins on complex assemblies.
  • Regulatory certifications and MDSAP membership support global medical device OEMs and enable faster market entry for clients needing compliant suppliers.
  • Exclusive license to process Torlon in India provides a differentiated offering for high-temperature, high-strength applications.

Shaily Engineering Plastics Limited (SHAILY.NS): How It Works

Shaily Engineering Plastics Limited (SHAILY.NS) operates as an integrated precision plastics manufacturer and contract manufacturer across multiple end-markets. Its operational model blends injection-moulding manufacturing, product development (including design for manufacturability), toolroom & mould-making, assembly and testing, plus regulated manufacturing lines for pharmaceutical and healthcare products.
  • Core activities: precision injection moulding, secondary operations (hot staking, ultrasonic welding, painting), sub-assembly, final product packaging and logistics.
  • Contract services: design, prototyping, validation, regulatory-compliant manufacturing for drug delivery devices and specialty packaging.
  • Quality & compliance: ISO, regulatory controls for pharma products, automotive QS/TS standards where applicable.
How It Makes Money
  • Manufacturing & Sales: Primary revenue from producing and selling precision injection-moulded plastic components and sub-assemblies to automotive, healthcare, consumer goods, lighting, appliances and electronics OEMs.
  • Contract Development & Manufacturing (CDMO-like services): Revenue from producing drug-delivery devices, specialty packaging, and containers for solid and liquid pharmaceutical formulations under contract with pharma firms.
  • Export Sales: Products exported to over 40 countries, enabling multinational contracts and diversified currency/market exposure.
  • Consumer Product Lines: Sales from kitchen and cooking devices, storage & cleaning products, and sheet-steel furniture items providing steady B2C/B2B revenue streams.
  • Value-added Services: Tooling & mould sales, after-sales services, and small-series manufacturing for new product launches add margin-accretive income.
Key commercial and financial metrics (approximate / illustrative):
Metric Value / Notes
Export reach Products exported to >40 countries
Planned capital expenditure ₹300-400 crores over next 3-4 years
Revenue split by end-market (estimate) Automotive 30% • Healthcare/Pharma 20% • Consumer goods 25% • Electronics/Appliances/Lighting 25%
Recent consolidated revenue (approx.) ~₹1,150 crore (FY recent, rounded)
Recent PAT (approx.) ~₹140 crore (FY recent, rounded)
Gross margin drivers Proprietary tooling, scale in injection-moulding, value-added assembly & pharma-regulated lines
Operational levers that drive profitability
  • Scale of moulding operations: high utilisation of injection-moulding machines and in-house toolrooms reduces per-unit costs.
  • Product mix: higher-margin pharma devices and specialty packaging vs. commodity components.
  • Export diversification: foreign contracts mitigate domestic cyclicality and enable higher ASPs for technical components.
  • Backward integration: in-house mould making and secondary operations shorten lead times and improve margins.
  • Capex-led growth: planned ₹300-400 crore investment aimed at expanding capacity, launching new pharma-compliant lines, and increasing high-margin product manufacturing.
Representative revenue map (indicative example of how sales flow by product category):
Product / Service Customers / End Markets Revenue Role
Precision injection-moulded automotive parts OEMs & Tier-1s (interior trims, functional components) Large-volume, steady revenue; seasonal OEM cycles
Pharma drug-delivery devices & specialty packaging Pharmaceutical companies, nutraceuticals Higher margin, regulated, contract manufacturing
Consumer goods (kitchenware, storage, cleaning) Retailers, distributors, direct-to-consumer Diversifies revenue; branded & private label sales
Lighting, appliances & electronics components Appliance manufacturers, electronics OEMs Mid-to-high volume; leverages precision tooling
Sheet steel furniture Institutional buyers, retailers Complementary product line; supports B2B contracts
For further background on the company's history, ownership and mission see: Shaily Engineering Plastics Limited: History, Ownership, Mission, How It Works & Makes Money

Shaily Engineering Plastics Limited (SHAILY.NS): How It Makes Money

Shaily Engineering Plastics generates revenue by supplying engineered plastic components and systems, primarily to the automotive sector, as well as consumer appliances and industrial customers. Its business model emphasizes high-precision injection molding, in-house tooling, design collaboration, and long-term contractual relationships that convert one-off orders into recurring multi-year engagements.
  • Core revenue streams: OEM automotive components (interior, exterior, under-the-hood), contract manufacturing, aftermarket parts, and exports.
  • Value-added services: product design & development, in-house toolmaking, color/texture engineering, and assembly/kitting for sub-systems.
  • Customer diversification: targeting new customers, geographies, and distribution channels to broaden the product pipeline and reduce concentration risk.
Metric Value / Note
Share price (as of Dec 15, 2025) ₹2,367.40
52-week high ₹2,799.20 (Nov 17, 2025)
Market capitalization Approximately ₹10,878 crore
Planned capex ₹300-400 crore over next 3-4 years
Recent investor engagement Participated in Kotak Manufacturing Conference, Aug 22, 2025, Mumbai
Revenue-generation mechanics:
  • Long-term supply contracts with OEMs: lock in multi-year volumes and price frameworks, improving revenue visibility.
  • Conversion strategy: turning one-off program wins into multi-year engagements to increase wallet share with existing customers.
  • Capacity expansion: planned capex (₹300-400 crore) to add presses, automation, and tooling capacity to capture larger order books and improve margins.
  • Geographic & channel expansion: opening new markets and distribution channels to monetize the evolving product pipeline.
  • Operational leverage: scale benefits from higher utilization, improved procurement, and process efficiencies to boost profit per unit.
Key market-position & future outlook points:
  • Strong market performance reflected in share-price appreciation and a recent 52-week high, supporting market confidence.
  • Market cap (~₹10,878 crore) positions Shaily as a significant mid-to-large player in engineered plastics for automotive and adjacent industries.
  • Active investor outreach (e.g., Kotak Manufacturing Conference) signals management focus on strategic growth and capital formation.
  • Planned capex and customer/geography diversification are expected to drive volume growth and higher revenue stability over the medium term.
Shaily Engineering Plastics Limited: History, Ownership, Mission, How It Works & Makes Money

DCF model

Shaily Engineering Plastics Limited (SHAILY.NS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.